Nantahala Capital Management, LLC Keros Therapeutics, Inc. Call Options Transaction History

Nantahala Capital Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$27.12 - $41.05 $24,408 - $36,945	-900 Reduced 7.32%	11,400 $453,000
Q1 2023 May 15, 2023	SELL	$41.44 - $59.32 $1.23 Million - $1.76 Million	-29,600 Reduced 70.64%	12,300 $525,000
Q1 2022 May 13, 2022	BUY	$42.12 - $59.36 $92,664 - $130,592	2,200 Added 5.54%	41,900 $2.28 Million
Q4 2021 Feb 14, 2022	BUY	$36.95 - $62.89 $1.47 Million - $2.5 Million	39,700 New	39,700 $2.32 Million

174

30.3M

76.8K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $439M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nantahala Capital Management, LLC with notifications on news.